fda used ‘critically flawed’ risk-benefit analysis 2 ‘justify’ covid vaccines children u.s. food drug administration relied critically flawed risk-benefit assessment 2 authorize emergency use pfizer’s covid-19 vax 4 children 5-11 yrs old. soruce defender